Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B

• Main Authors: Kerui Xu (Author), Li-Ming Liu (Author), Paraskevi A. Farazi (Author), Hongmei Wang (Author), Fedja A Rochling (Author), Shinobu Watanabe-Galloway (Author), Jian-Jun Zhang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Globally, of the 248 million people chronically infected with the hepatitis B virus (HBV), 74 million reside in China. Five oral nucleot(s)ide analogs (NUCs) have been approved for the treatment of chronic hepatitis B (CHB) in China. Objectives: The aims of this study were to determine r...